431 related articles for article (PubMed ID: 34793866)
1. A new perspective on NAFLD: Focusing on lipid droplets.
Scorletti E; Carr RM
J Hepatol; 2022 Apr; 76(4):934-945. PubMed ID: 34793866
[TBL] [Abstract][Full Text] [Related]
2. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
Mashek DG
Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights.
Mass Sanchez PB; Krizanac M; Weiskirchen R; Asimakopoulos A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067931
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and non-alcoholic fatty liver diseases.
Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
[TBL] [Abstract][Full Text] [Related]
5. Biomechanics of cultured hepatic cells during different steatogenic hits.
Baldini F; Bartolozzi A; Ardito M; Voci A; Portincasa P; Vassalli M; Vergani L
J Mech Behav Biomed Mater; 2019 Sep; 97():296-305. PubMed ID: 31151002
[TBL] [Abstract][Full Text] [Related]
6. Exercise regulation of hepatic lipid droplet metabolism.
Pino-de la Fuente F; Bórquez JC; Díaz-Castro F; Espinosa A; Chiong M; Troncoso R
Life Sci; 2022 Jun; 298():120522. PubMed ID: 35367244
[TBL] [Abstract][Full Text] [Related]
7. Mitofusin-2 induced by exercise modifies lipid droplet-mitochondria communication, promoting fatty acid oxidation in male mice with NAFLD.
Bórquez JC; Díaz-Castro F; La Fuente FP; Espinoza K; Figueroa AM; Martínez-Ruíz I; Hernández V; López-Soldado I; Ventura R; Domingo JC; Bosch M; Fajardo A; Sebastián D; Espinosa A; Pol A; Zorzano A; Cortés V; Hernández-Alvarez MI; Troncoso R
Metabolism; 2024 Mar; 152():155765. PubMed ID: 38142958
[TBL] [Abstract][Full Text] [Related]
8. Deranged hepatocyte intracellular Ca
Ali ES; Rychkov GY; Barritt GJ
Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
[TBL] [Abstract][Full Text] [Related]
9. Hepatic lipid droplet homeostasis and fatty liver disease.
Seebacher F; Zeigerer A; Kory N; Krahmer N
Semin Cell Dev Biol; 2020 Dec; 108():72-81. PubMed ID: 32444289
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of lipophagy in liver disorders.
Nazeer B; Khawar MB; Khalid MU; Hamid SE; Rafiq M; Abbasi MH; Sheikh N; Ali A; Fatima H; Ahmad S
Mol Cell Biochem; 2024 Jan; 479(1):1-11. PubMed ID: 36943663
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on Mitochondria-ER and Mitochondria-Lipid Droplet Contact in Hepatocytes and Hepatic Lipid Metabolism.
Ma X; Qian H; Chen A; Ni HM; Ding WX
Cells; 2021 Sep; 10(9):. PubMed ID: 34571924
[TBL] [Abstract][Full Text] [Related]
12. [Lipid droplet-associated proteins. Importance in steatosis, steatohepatitis and hepatocarcinogenesis].
Straub BK
Pathologe; 2015 Nov; 36 Suppl 2():146-52. PubMed ID: 26400566
[TBL] [Abstract][Full Text] [Related]
13. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine.
Grasselli E; Canesi L; Portincasa P; Voci A; Vergani L; Demori I
Ann Hepatol; 2017; 16(5):707-719. PubMed ID: 28809727
[TBL] [Abstract][Full Text] [Related]
14. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
[TBL] [Abstract][Full Text] [Related]
16. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits.
Peiseler M; Schwabe R; Hampe J; Kubes P; Heikenwälder M; Tacke F
J Hepatol; 2022 Oct; 77(4):1136-1160. PubMed ID: 35750137
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of lipid droplet proteins in liver diseases.
Carr RM; Ahima RS
Exp Cell Res; 2016 Jan; 340(2):187-92. PubMed ID: 26515554
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional analysis of the expression and prognostic value of lipid droplet-localized proteins in hepatocellular carcinoma.
Zhang Y; Liang X; Lian Q; Liu L; Zhang B; Dong Z; Liu K
BMC Cancer; 2023 Jul; 23(1):677. PubMed ID: 37464334
[TBL] [Abstract][Full Text] [Related]
19. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Wu J
Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
[TBL] [Abstract][Full Text] [Related]
20. Research Progress on Lipophagy-Mediated Exercise Intervention in Non-Alcoholic Fatty Liver Disease.
Li X; Yang Y; Sun Y; Ding S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
